Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
Rhea-AI Summary
Quantum Computing Inc (Nasdaq: QUBT) announced an oversubscribed private placement of 26,867,276 shares priced at market to raise approximately $500 million gross. The company said the offering includes participation by several large existing shareholders and a first-time investment from a global alternative asset manager. The closing is expected on or about September 24, 2025, subject to customary conditions. The company intends to use net proceeds for commercialization, strategic acquisitions, sales and engineering hires, working capital, and general corporate purposes. The securities have not been registered under the Securities Act; the company agreed to file a resale registration statement. The company reported total gross capital raised since November 2024 of approximately $900 million and an expected post-close cash position of about $850 million.
Positive
- Gross proceeds of $500 million from the private placement
- 26,867,276 shares issued in an oversubscribed offering
- Total gross capital raised of approximately $900 million since November 2024
- Expected post-close $850 million total cash position
Negative
- Securities not registered under the Securities Act, limiting immediate resale in the US
Market Reaction 15 min delay 15 Alerts
Following this news, TFX has gained 9.69%, reflecting a notable positive market reaction. Our momentum scanner has triggered 15 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $131.43. This price movement has added approximately $513M to the company's valuation.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.
Key Figures
Market Reality Check
Peers on Argus
Teleflex slipped 0.56% while key medical instrument peers like MMSI, BLCO, RGEN, STVN and NVST also traded lower (moves from -0.44% to -2.14%), suggesting a generally weak tape but without confirmed sector-wide momentum.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 14 | Conference appearance | Neutral | -2.2% | Jefferies London conference presentation and webcast details for investors. |
| Nov 06 | Dividend declaration | Positive | -13.0% | Announcement of a <b>$0.34</b> per share quarterly cash dividend. |
| Nov 06 | Earnings and outlook | Negative | -13.0% | Q3 results with large goodwill impairments and reduced EPS guidance. |
| Oct 16 | Earnings call info | Neutral | +3.4% | Scheduling details for Q3 2025 earnings call and VI investor meeting. |
| Sep 11 | Clinical trial start | Positive | +1.7% | First patient enrolled in DUBSTENT DIABETES PCI strategy trial in diabetics. |
Recent Teleflex news often saw outsized downside on financial updates, with the Q3 2025 earnings and dividend announcements both followed by double‑digit percentage declines despite generally informational or mixed content.
Over the last six months, Teleflex has combined clinical, strategic, and financial developments. Q3 2025 results showed GAAP revenue of $913.0M and significant non‑cash impairments totaling about $512.0M, alongside lowered EPS guidance, and the stock fell 13.02%. A quarterly dividend of $0.34 per share and conference appearances around earnings also coincided with weakness. Clinically, the DUBSTENT DIABETES trial began enrolling 120 patients, marking ongoing innovation in PCI strategies.
Market Pulse Summary
The stock is up +9.7% following this news. A strong positive reaction aligns with the sizable equity financing described, which adds an expected $500 million in gross proceeds and lifts the total cash position toward $850 million. Historically, Teleflex’s stock has reacted sharply to financial updates, especially those involving earnings and impairments. Investors would need to weigh balance sheet strengthening and growth funding against potential dilution from issuing 26,867,276 new shares and the risk that enthusiasm for capital raises can fade once the deal is fully absorbed.
Key Terms
securities purchase agreements financial
private placement financial
alternative asset manager financial
resale registration statement regulatory
AI-generated analysis. Not financial advice.
-
The offering is being led by several large existing shareholders alongside a first-time investment from a preeminent global alternative asset manager
-
Company's total cash position expected to be approximately
following closing$850 million
Participants in the private placement include several large existing shareholders alongside a first-time investment from a preeminent global alternative asset manager.
The Company intends to use the net proceeds from the offering to accelerate commercialization efforts, strategic acquisitions, expand sales and engineering personnel, working capital, and general corporate purposes.
Titan Partners Group, a division of American Capital Partners, is acting as the sole placement agent for the offering.
"This successful
The securities issued in the private placement described above have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Quantum Computing Inc.
Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT) is an innovative, integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines and foundry services for the production of photonic chips based on thin-film lithium niobate (TFLN). QCi's products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer unique capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
Forward-Looking Statements
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, generally identified by terms such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," "aim to," or variations of these or similar words, involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future. Those statements include statements regarding and including statements regarding the expected closing of the offering, QCi's use of the net proceeds from the offering and the anticipated benefits that the Company may realize from the offering. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including the timing of orders and revenue, and the outcome of ongoing collaborations and demonstration projects with certain
Company Contact:
Rosalyn Christian/John Nesbett
IMS Investor Relations
View original content to download multimedia:https://www.prnewswire.com/news-releases/quantum-computing-inc-announces-500-million-oversubscribed-private-placement-of-common-stock-priced-at-the-market-under-nasdaq-rules-302562474.html
SOURCE Quantum Computing Inc.